Randomized phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS): Survival results after 2 years of follow-up and intratumoral B-cell receptor (BCR) correlates.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emily Zhi-Yun Keung, Elise F Nassif, Heather Y. Lin, Alexander J. Lazar, Keila E Torres, Wei-Lien Wang, Beverly Ashleigh Guadagnolo, Andrew Justin Bishop, Kelly Hunt, Barry W. Feig, Justin E. Bird, Valerae O. Lewis, Ravin Ratan, Shreyaskumar Patel, Monika Zelazowska, Bin Liu, Kevin McBride, Jennifer Ann Wargo, Christina Lynn Roland, Neeta Somaiah
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4293083582